CIK 0001756262
- Large accelerated filer
TransMedics Group, Inc.
Sign in to watch- Ticker
- TMDX
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- Phone
- +1 978-552-0900
- Business address
- 200 MINUTEMAN ROAD, ANDOVER, MA, 01810
- 4 Grant or award Director acquired 732 shares (grant or award)
- 4 Grant or award Director acquired 732 shares (grant or award)
- 4 Grant or award Director acquired 732 shares (grant or award)
- 4 Planned sale President & CEO sold 8,625 shares at an average $135.32 ($1,167,147)
- 4 Open-market sale Director sold 2,500 shares at $129.82 ($324,550)
- 4/A Insider Changes in Ownership
- 4/A Planned sale Chief Commercial Officer sold 63,260 shares at an average $108.54 ($6,866,104)
- 4 Open-market sale Corcoran Nicholas sold 3,222 shares at $129.91 ($418,570)
- 4 Planned sale Chief Financial Officer sold 15,000 shares at $128.00 ($1,920,000)
- 4 Planned sale Director sold 7,157 shares at an average $129.98 ($930,278)
- 4 Planned sale Chief Commercial Officer sold 5,839 shares at $130.07 ($759,479)
- 4 Planned sale President & CEO sold 30,000 shares at $130.07 ($3,902,100)
- 4 Planned sale Director sold 12,025 shares at an average $125.05 ($1,503,687)
- 4 Planned sale Director sold 15,040 shares at an average $106.43 ($1,600,633)
- 4 Planned sale President & CEO sold 68,444 shares at an average $116.68 ($7,986,219)
- 4 Planned sale Chief Commercial Officer sold 78,036 shares at an average $109.78 ($8,566,837)
- 4 Planned sale President & CEO sold 4,000 shares at $95.12 ($380,480)
- 4 Planned sale President & CEO sold 12,000 shares at $95.09 ($1,141,080)
- 4 Planned sale Chief Commercial Officer sold 19,900 shares at an average $90.35 ($1,798,002)
- 4 Planned sale Chief Commercial Officer sold 10,000 shares at an average $80.21 ($802,084)
Page 5 of 18 · 358 filings